{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:16:12Z","timestamp":1788218172595,"version":"build-2803163510"},"reference-count":35,"publisher":"American Chemical Society (ACS)","issue":"33","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFD251"],"award-info":[{"award-number":["2025AFD251"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042024YXB014"],"award-info":[{"award-number":["2042024YXB014"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"publisher","award":["ZNJC202323"],"award-info":[{"award-number":["ZNJC202323"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171922"],"award-info":[{"award-number":["82171922"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide, highlighting the urgent need for safe and effective imaging tools to improve early diagnosis. In this study, we developed a hepatocyte-targeted T2 MRI contrast agent by functionalizing superparamagnetic iron oxide nanoparticles (SPIONs) with an ethoxybenzyl-polyethylene glycol ligand, yielding Fe3O4-EOB-PEG2000 NPs, inspired by the hepatocyte-selective features of Gd-EOB-DTPA. In vitro studies demonstrated preferential uptake of Fe3O4-EOB-PEG2000 NPs by hepatocytes over tumor cells, while in vivo imaging in both hepatocellular carcinoma and colorectal liver metastasis models revealed a distinct \u201cblack-liver\/bright-tumor\u201d contrast effect. Compared with nontargeted Fe3O4-mPEG2000 NPs, Fe3O4-EOB-PEG2000 NPs showed significantly improved tumor visibility in T2-weighted images. Furthermore, Fe3O4-EOB-PEG2000 NPs exhibited good biocompatibility and biosafety. This work highlights a strategy for enhancing T2 MRI contrast through hepatocyte targeting, providing a promising gadolinium-free alternative for safe and effective safe and effective diagnosis of liver tumors.<\/jats:p>","DOI":"10.1021\/acs.analchem.6c00502","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:01:53Z","timestamp":1786593713000},"page":"24012-24023","source":"Crossref","is-referenced-by-count":0,"title":["Iron Oxide\nNanoparticles for Hepatocyte-Targeted T2\nImaging with Inverse Illumination of Liver Tumors"],"prefix":"10.1021","volume":"98","author":[{"given":"Wang","family":"Qian","sequence":"first","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyang","family":"Suo","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ma","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ling","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qiu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-2295","authenticated-orcid":true,"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Wei","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University , , ,","place":["Wuhan, P. R. China, 430071"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"3","key":"2026083118451722500_cit1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN\nestimates of incidence and mortality worldwide for 36 cancers in 185\ncountries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca-Cancer J. Clin."},{"issue":"10360","key":"2026083118451722500_cit2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular\ncarcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"2026083118451722500_cit3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global Epidemiology\nand Genetics\nof Hepatocellular Carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"6","key":"2026083118451722500_cit4","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance\non prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"12","key":"2026083118451722500_cit5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global\ntrends in hepatocellular carcinoma\nepidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"2026083118451722500_cit6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","article-title":"Guidelines for the Diagnosis and Treatment of Primary Liver Cancer\n(2022 Edition)","volume":"12","author":"Zhou","year":"2023","journal-title":"Liver Cancer"},{"issue":"43","key":"2026083118451722500_cit7","doi-asserted-by":"publisher","first-page":"17025","DOI":"10.1021\/jacs.9b09149","article-title":"Molecular Magnetic\nResonance Imaging with Gd(III)-Based\nContrast Agents: Challenges and Key Advances","volume":"141","author":"Li","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"2026083118451722500_cit8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25 Years of Contrast-Enhanced MRI: Developments, Current\nChallenges and Future Perspectives","volume":"33","author":"Lohrke","year":"2016","journal-title":"Adv. Ther."},{"issue":"2","key":"2026083118451722500_cit9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI Contrast\nAgents: Current Challenges and New Frontiers","volume":"119","author":"Wahsner","year":"2019","journal-title":"Chem. Rev."},{"issue":"1","key":"2026083118451722500_cit10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/hep.29487","article-title":"Imaging for\nthe diagnosis\nof hepatocellular carcinoma: A systematic review and meta-analysis","volume":"67","author":"Roberts","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"2026083118451722500_cit11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1148\/radiol.14132361","article-title":"CT and MR imaging diagnosis and staging\nof hepatocellular carcinoma: part I. Development, growth, and spread:\nkey pathologic and imaging aspects","volume":"272","author":"Choi","year":"2014","journal-title":"Radiology"},{"issue":"7","key":"2026083118451722500_cit12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00535-009-0056-4","article-title":"Expression of OATP1B3\ndetermines uptake of Gd-EOB-DTPA in hepatocellular carcinoma","volume":"44","author":"Narita","year":"2009","journal-title":"J. Gastroenterol."},{"issue":"6","key":"2026083118451722500_cit13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00330-010-2030-1","article-title":"Contribution of the\nhepatobiliary phase of Gd-EOB-DTPA-enhanced\nMRI to Dynamic MRI in the detection of hypovascular small (\u22642\ncm) HCC in cirrhosis","volume":"21","author":"Golfieri","year":"2011","journal-title":"Eur. Radiol."},{"issue":"9","key":"2026083118451722500_cit14","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected\ncausative role of gadodiamide used for contrast-enhanced magnetic\nresonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"2026083118451722500_cit15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1053\/j.ajkd.2020.07.012","article-title":"Risks and\nOptions With Gadolinium-Based Contrast Agents in Patients With CKD:\nA Review","volume":"77","author":"Rudnick","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"2026083118451722500_cit16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based\nContrast Agent Accumulates in the Brain Even in Subjects without Severe\nRenal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively\nCoupled Plasma Mass Spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"2026083118451722500_cit17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1148\/radiol.212600","article-title":"Long-term Gadolinium Retention in\nthe Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol,\nand Gadodiamide","volume":"305","author":"Funke","year":"2022","journal-title":"Radiology"},{"issue":"3","key":"2026083118451722500_cit18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41551-022-00975-2","article-title":"A hepatocyte-targeting\nnanoparticle for enhanced hepatobiliary magnetic resonance imaging","volume":"7","author":"Zhang","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"2026083118451722500_cit19","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae057","article-title":"Unveiling\nthe next generation of MRI contrast agents:\ncurrent insights and perspectives on ferumoxytol-enhanced MRI","volume":"11","author":"Si","year":"2024","journal-title":"Natl. Sci. Rev."},{"issue":"7","key":"2026083118451722500_cit20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41575-024-00926-z","article-title":"New understanding of\nhepatobiliary MRI","volume":"21","author":"Pastor","year":"2024","journal-title":"Nat. Rev. Gastroenterol.\nHepatol."},{"issue":"4","key":"2026083118451722500_cit21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/jmri.24691","article-title":"Emerging\napplications\nfor ferumoxytol as a contrast agent in MRI","volume":"41","author":"Bashir","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"2026083118451722500_cit22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/jmri.27405","article-title":"Safety of Off-Label\nUse of Ferumoxtyol as a Contrast\nAgent for MRI: A Systematic Review and Meta-Analysis of Adverse Events","volume":"53","author":"Ahmad","year":"2021","journal-title":"J. Magn. Reson. Imaging"},{"key":"2026083118451722500_cit23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles:\nDiagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Delivery Rev."},{"issue":"15","key":"2026083118451722500_cit24","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1517\/14656560903224998","article-title":"Ferumoxytol\nfor treatment of iron deficiency anemia in patients with chronic kidney\ndisease","volume":"10","author":"Coyne","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"2026083118451722500_cit25","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/trf.15587","article-title":"The safety\nand efficacy of ferumoxytol in the treatment of iron deficiency: a\nsystematic review and meta-analysis","volume":"59","author":"Abdulrehman","year":"2019","journal-title":"Transfusion"},{"key":"2026083118451722500_cit26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.921667","article-title":"Contrast Agents for\nHepatocellular Carcinoma Imaging: Value and Progression","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"32","key":"2026083118451722500_cit27","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1021\/ja203340u","article-title":"Large-scale\nsynthesis of uniform\nand extremely small-sized iron oxide nanoparticles for high-resolution\nT1 magnetic resonance imaging contrast agents","volume":"133","author":"Kim","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"2026083118451722500_cit28","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1073\/pnas.1620145114","article-title":"Exceedingly small iron oxide nanoparticles\nas positive MRI contrast agents","volume":"114","author":"Wei","year":"2017","journal-title":"Proc. Natl.\nAcad. Sci. U.S.A."},{"issue":"4","key":"2026083118451722500_cit29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1177\/02841851221136499","article-title":"Utility of combined\ngadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative\ndetection of colorectal cancer liver metastases: a pilot study","volume":"64","author":"Carney","year":"2023","journal-title":"Acta Radiol."},{"issue":"2","key":"2026083118451722500_cit30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejrad.2005.11.040","article-title":"Application\nof superparamagnetic iron oxide to imaging\nof hepatocellular carcinoma","volume":"58","author":"Tanimoto","year":"2006","journal-title":"Eur. J. Radiol."},{"issue":"21","key":"2026083118451722500_cit31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215269","article-title":"Quantifying Liver Heterogeneity via\nR2*-MRI with Super-Paramagnetic Iron Oxide Nanoparticles (SPION) to\nCharacterize Liver Function and Tumor","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"2026083118451722500_cit32","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1002\/jum.14926","article-title":"Comparison\nBetween Low Mechanical Index and High Mechanical Index Contrast Modes\nof Contrast-Enhanced Ultrasonography: Evaluation of Perfusion Defects\nof Hypervascular Hepatocellular Carcinomas During the Post-Vascular\nPhase","volume":"38","author":"Duisyenbi","year":"2019","journal-title":"J. Ultrasound Med."},{"issue":"12","key":"2026083118451722500_cit33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nmat1251","article-title":"Ultra-large-scale syntheses\nof monodisperse nanocrystals","volume":"3","author":"Park","year":"2004","journal-title":"Nat. Mater."},{"issue":"4","key":"2026083118451722500_cit34","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1021\/acsnano.6b07684","article-title":"Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic\nSimultaneous Thermal Decomposition for High-Performance and Multifunctional\nT(1) Magnetic Resonance Imaging Contrast Agent","volume":"11","author":"Zhang","year":"2017","journal-title":"ACS Nano"},{"key":"2026083118451722500_cit35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3266","article-title":"Octapod iron oxide nanoparticles as high-performance T(2) contrast\nagents for magnetic resonance imaging","volume":"4","author":"Zhao","year":"2013","journal-title":"Nat.\nCommun."}],"container-title":["Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.analchem.6c00502","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/33\/24012\/66521419\/acs.analchem.6c00502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/33\/24012\/66521419\/acs.analchem.6c00502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:45:24Z","timestamp":1788216324000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancham\/article\/98\/33\/24012\/5254051\/Iron-Oxide-Nanoparticles-for-Hepatocyte-Targeted"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":35,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2026,8,12]]},"published-print":{"date-parts":[[2026,8,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.analchem.6c00502","relation":{},"ISSN":["0003-2700","1520-6882"],"issn-type":[{"value":"0003-2700","type":"print"},{"value":"1520-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}